Pneumococcal Conjugate Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pneumococcal Conjugate Vaccine (PCV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumococcal Conjugate Vaccine (PCV) Overall Market Size
2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size: 2022 VS 2029
2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pneumococcal Conjugate Vaccine (PCV) Players in Global Market
3.2 Top Global Pneumococcal Conjugate Vaccine (PCV) Companies Ranked by Revenue
3.3 Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Companies
3.4 Top 3 and Top 5 Pneumococcal Conjugate Vaccine (PCV) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pneumococcal Conjugate Vaccine (PCV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Players in Global Market
3.6.1 List of Global Tier 1 Pneumococcal Conjugate Vaccine (PCV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Market Size Markets, 2022 & 2029
4.1.2 23-valent Vaccine
4.1.3 10-valent Vaccine
4.1.4 7-valent Vaccine
4.1.5 13-valent Vaccine
4.2 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
4.2.1 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2023
4.2.2 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2024-2029
4.2.3 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Market Size, 2022 & 2029
5.1.2 Child
5.1.3 Adult
5.2 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
5.2.1 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2023
5.2.2 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2024-2029
5.2.3 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Market Size, 2022 & 2029
6.2 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
6.2.1 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2023
6.2.2 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2024-2029
6.2.3 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
6.3.2 US Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.3.3 Canada Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.3.4 Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
6.4.2 Germany Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4.3 France Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4.4 U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4.5 Italy Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4.6 Russia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4.7 Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.4.8 Benelux Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
6.5.2 China Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.5.3 Japan Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.5.4 South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.5.5 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.5.6 India Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
6.6.2 Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.6.3 Argentina Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029
6.7.2 Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.7.3 Israel Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.7.4 Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
6.7.5 UAE Pneumococcal Conjugate Vaccine (PCV) Market Size, 2018-2029
7 Pneumococcal Conjugate Vaccine (PCV) Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.1.4 Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.2.4 GSK Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.3.4 Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.4.4 Merck Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Company Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.5.4 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.5.5 Walvax Biotechnology Key News & Latest Developments
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Company Summary
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
7.7 Zhifei Biologic
7.7.1 Zhifei Biologic Company Summary
7.7.2 Zhifei Biologic Business Overview
7.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.7.4 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.7.5 Zhifei Biologic Key News & Latest Developments
7.8 Serum Institute of India
7.8.1 Serum Institute of India Company Summary
7.8.2 Serum Institute of India Business Overview
7.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.8.4 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2018-2023)
7.8.5 Serum Institute of India Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pneumococcal Conjugate Vaccine (PCV) Market Opportunities & Trends in Global Market
Table 2. Pneumococcal Conjugate Vaccine (PCV) Market Drivers in Global Market
Table 3. Pneumococcal Conjugate Vaccine (PCV) Market Restraints in Global Market
Table 4. Key Players of Pneumococcal Conjugate Vaccine (PCV) in Global Market
Table 5. Top Pneumococcal Conjugate Vaccine (PCV) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pneumococcal Conjugate Vaccine (PCV) Product Type
Table 9. List of Global Tier 1 Pneumococcal Conjugate Vaccine (PCV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 32. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. GSK Company Summary
Table 35. GSK Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 36. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 37. GSK Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 40. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 44. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Walvax Biotechnology Company Summary
Table 47. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 48. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 49. Walvax Biotechnology Key News & Latest Developments
Table 50. Royal (Wuxi) Bio-Pharmaceutical Company Summary
Table 51. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 52. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 53. Royal (Wuxi) Bio-Pharmaceutical Key News & Latest Developments
Table 54. Zhifei Biologic Company Summary
Table 55. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 56. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 57. Zhifei Biologic Key News & Latest Developments
Table 58. Serum Institute of India Company Summary
Table 59. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 60. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn) & (2018-2023)
Table 61. Serum Institute of India Key News & Latest Developments
List of Figures
Figure 1. Pneumococcal Conjugate Vaccine (PCV) Segment by Type in 2022
Figure 2. Pneumococcal Conjugate Vaccine (PCV) Segment by Application in 2022
Figure 3. Global Pneumococcal Conjugate Vaccine (PCV) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2022
Figure 8. By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 16. US Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 20. Germany Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 21. France Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 28. China Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 32. India Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 34. Brazil Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2018-2029
Figure 37. Turkey Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
